← All stories
Markets
Avicanna Announces Closing of Strategic Non-Brokered Private Placement
Strategic investment by pharmaceutical executive and life sciences investor Michael Porter TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) — Avicanna Inc. (“Avicanna” or the “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical comp…
Covered by 1 outlet
All coverage · 1 article